Clinical trials
Brain Injuries, Traumatic trials in Canada with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 9 |
| Recruiting | 5 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of British Columbia | 4 |
| CHU de Quebec-Universite Laval | 3 |
| Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal | 2 |
| University Health Network, Toronto | 2 |
| University of Alberta | 2 |
| University of Calgary | 2 |
| University of Manitoba | 2 |
| Baycrest | 1 |
| Dr. Michael Esser | 1 |
| Dr. Stephen Robinovitch | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Injuries, Traumatic | 31 |
| Brain Injuries | 11 |
| Stroke | 8 |
| Brain Concussion | 4 |
| Brain Neoplasms | 3 |
| Wounds and Injuries | 3 |
| Cerebral Palsy | 2 |
| Hemianopsia | 2 |
| Post-Concussion Syndrome | 2 |
| Spinal Cord Injuries | 2 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.